Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Bähring, Sylvia Dr. (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Hinz, Michael Dr. (1) Keller, Ulrich Dr. med. (1) Lohse, Martin Prof. Dr. (1) Luft, Friedrich Prof. Dr. (1) Lusatis, Simone (1) Martin, Lisa Maria (1) Roske, Yvette Dr. (1) Rrustemi, Trendelina (2) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (5) Stein, Ulrike Prof. Dr. (1) Uyar, Bora Dr. (1) Walther, Wolfgang Prof. Dr. (1) Wollert-Wulf, Brigitte (2) Zauber, Henrik Dr. (1) (-) Janz, Martin Dr. (8) (-) Mathas, Stephan Dr. (6) 1999 (2) 2000 (2) 2001 (1) 2002 (6) (-) 2003 (3) 2004 (3) 2005 (3) (-) 2006 (5) 2007 (4) 2008 (4) 2009 (4) 2010 (3) 2011 (4) 2012 (2) 2013 (3) 2014 (3) 2015 (5) 2016 (3) 2017 (5) 2018 (1) 2019 (2) 2020 (6) 2021 (3) 2022 (7) (-) 2024 (2) (-) Biology of Malignant Lymphomas (10) Genetics and Genomics of Cardiovascular Diseases (1) Mechanism-based Cancer Therapies (1) Molecular Immunology and Gene Therapy (12) Translational Oncology of Solid Tumors (1) 10 Results: Active Filter: Janz, Martin Dr.Mathas, Stephan Dr.Biology of Malignant Lymphomas200320062024 Sort: Result score Newest to oldest Oldest to newest March 01, 2024 / Lancet Haematol High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial E. Schorb L.K. Isbell A. Kerkhoff S. Mathas F. Braulke G. Egerer A. Röth S. Schliffke P. Borchmann U. Brunnberg F. Kroschinsky R. Möhle A. Rank D. Wellnitz B. Kasenda L. Pospiech J. Wendler F. Scherer M. Deckert E. Henkes P. von Gottberg D. Gmehlin M. Backenstraß A. Jensch E. Burger-Martin O. Grishina H. Fricker N. Malenica A. Orbán J. Duyster G. Ihorst J. Finke G. Illerhaus January 01, 2024 / Eur J Cancer A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma S. Habringer U.M. Demel A.K. Fietz F. Lammer R. Schroers S. Hofer O. Bairey J. Braess A.S. Meier-Stiegen R. Stuhlmann M. Schmidt-Hieber J. Hoffmann B. Zinngrebe U. Kaiser P. Reimer R. Möhle P. Fix H.G. Höffkes U. Langenkamp C.M.Z. Büschenfelde O. Hopfer A. Stoltefuß P. La Rosée H. Blasberg K. Jordan S. Kaun A. Meurer M. Unteroberdörster A.C. von Brünneck D. Capper F.L. Heppner B. Chapuy M. Janz S. Schwartz F. Konietschke P. Vajkoczy A. Korfel U. Keller January 01, 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer August 01, 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken May 01, 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas July 01, 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken
March 01, 2024 / Lancet Haematol High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial E. Schorb L.K. Isbell A. Kerkhoff S. Mathas F. Braulke G. Egerer A. Röth S. Schliffke P. Borchmann U. Brunnberg F. Kroschinsky R. Möhle A. Rank D. Wellnitz B. Kasenda L. Pospiech J. Wendler F. Scherer M. Deckert E. Henkes P. von Gottberg D. Gmehlin M. Backenstraß A. Jensch E. Burger-Martin O. Grishina H. Fricker N. Malenica A. Orbán J. Duyster G. Ihorst J. Finke G. Illerhaus
January 01, 2024 / Eur J Cancer A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma S. Habringer U.M. Demel A.K. Fietz F. Lammer R. Schroers S. Hofer O. Bairey J. Braess A.S. Meier-Stiegen R. Stuhlmann M. Schmidt-Hieber J. Hoffmann B. Zinngrebe U. Kaiser P. Reimer R. Möhle P. Fix H.G. Höffkes U. Langenkamp C.M.Z. Büschenfelde O. Hopfer A. Stoltefuß P. La Rosée H. Blasberg K. Jordan S. Kaun A. Meurer M. Unteroberdörster A.C. von Brünneck D. Capper F.L. Heppner B. Chapuy M. Janz S. Schwartz F. Konietschke P. Vajkoczy A. Korfel U. Keller
January 01, 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer
August 01, 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken
May 01, 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
July 01, 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken